経皮吸収型スキンパッチの世界市場レポート 2024

経皮吸収型スキンパッチの市場規模は、今後数年間で着実に成長すると予想されています。 2028年には4.1%の年間複合成長率（CAGR）で90億2,000万米ドルに成長すると予想されます。予測期間の増加は、禁煙への注目の高まり、高齢化人口の急速な増加、ヘルスケア費の増加、心血管疾患の急増などの要因に起因すると考えられます。予測期間の主な動向には、経皮吸収型スキンパッチの技術的進歩、糖尿病用経皮パッチの進歩、活発な研究開発活動、製品イノベーション、共同研究およびパートナーシップ、ウェアラブル皮膚パッチの出現、ワクチン接種用マイクロニードルパッチの進歩、新しいイオントフォレーシスパッチの導入などがあります。

心血管疾患の有病率の上昇は、将来経皮吸収型スキンパッチ市場の成長を促進すると予想されます。心血管疾患は心臓と血管に影響を与え、多くの場合、動脈内の脂肪沈着物の発生（アテローム性動脈硬化症）や血栓のリスクの増加を伴います。 経皮吸収型スキンパッチは、冠状動脈疾患（心臓に血液を供給する血管の狭窄）を持つ人の狭心症発作（胸痛）を予防し、心不全治療の生物学的利用能を高めるために利用されます。たとえば、2023年 5月、疾病管理予防センターは、2021年に米国で約695,000人が心臓病で死亡し、死亡者の5人に1人が死亡したと報告しました。最も蔓延しているタイプの冠状動脈性心疾患は、2021年に375,476人が死亡しました。その結果、心血管疾患の有病率の増加が経皮吸収型スキンパッチ市場の拡大を牽引しています。

経皮吸収型スキンパッチ市場の成長は、最新テクノロジーの進歩に大きく影響されます。これらの技術の進歩により、経皮的に送達できる薬剤の範囲が拡大しており、小分子の疎水性薬剤、親水性薬剤、高分子が含まれています。強化された技術力は、効率の向上と経皮ドラッグデリバリーシステム（TDDS）の幅広い採用に貢献し、その結果、TDDSの人気と需要が高まります。たとえば、2022年 9月に、米国に本拠を置くバイオ医薬品会社であるCoriumは、アルツハイマー病の治療のために設計された経皮パッチであるAdlarityを発売しました。独自のCorplexテクノロジーを利用して、Adlarityはドネペジルの制御された持続放出を提供し、さまざまな重症度レベルにわたってアルツハイマー病関連認知症患者に利益をもたらします。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の経皮吸収型スキンパッチ市場、製品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• マトリックス
• 薬物溶解型接着剤
• 貯水池
• 蒸気
• 世界の経皮吸収型スキンパッチ市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• フェンタニル経皮パッチ
• ニコチン経皮パッチ
• ブプレノルフィン経皮パッチ
• クロニジン経皮パッチ
• オキシブチニン経皮パッチ
• その他のタイプ
• 世界の経皮吸収型スキンパッチ市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 鎮痛剤
• ニコチンの禁煙
• ホルモン補充療法
• 神経学的障害
• 心血管疾患
• その他の用途

第7章 地域および国の分析

• 世界の経皮吸収型スキンパッチ市場、地域別、実績および予測、2018-2023、2023-2028年、2033年
• 世界の経皮吸収型スキンパッチ市場、国別、実績および予測、2018-2023年、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 経皮吸収型スキンパッチ市場の競合情勢
• 経皮吸収型スキンパッチ市場の企業プロファイル
  • Novartis
  • Hisamitsu Pharmaceutical Co., Inc
  • Henan Lingrui Pharmaceutical
  • Teva Pharmaceuticals
  • Luye Pharma Group Ltd

第31章 その他の大手および革新的な企業

• Purdue Pharma LP
• Nitto Denko Corporation
• AdhexPharma
• Noven Pharmaceuticals
• Teikoku Pharma
• Mylan Pharmaceuticals Inc
• 3M Company
• Acrux Ltd
• Access Pharmaceuticals Inc
• Rusan Pharma
• Glenmark Pharmaceuticals
• Cipla Ltd
• Mundipharma
• Dr Reddy's Laboratories
• Chattem

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Transdermal skin patches represent a drug delivery method wherein a predetermined dose of medication is administered through an adhesive patch, absorbing into the bloodstream via the skin. These patches offer a precise and predetermined dosage of medication, facilitating absorption through the skin into the bloodstream.

The primary categories within the transdermal skin patches market include fentanyl transdermal patches, nicotine transdermal patches, buprenorphine transdermal patches, clonidine transdermal patches, oxybutynin transdermal patches, and others. Nicotine transdermal skin patches are designed to aid individuals in quitting smoking by providing a controlled source of nicotine through the skin, helping alleviate withdrawal symptoms associated with smoking cessation. Various products in this market utilize matrix, drugs in the adhesive, reservoir, and vapor technologies, catering to applications such as pain relief, nicotine cessation, hormone replacement therapy, as well as addressing neurological and cardiovascular disorders, among others.

The transdermal skin patches market research report is one of a series of new reports from The Business Research Company that provides transdermal skin patches market statistics, including transdermal skin patches industry global market size, regional shares, competitors with a transdermal skin patches market share, detailed transdermal skin patches market segments, market trends and opportunities, and any further data you may need to thrive in the transdermal skin patches industry. This transdermal skin patches market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The transdermal skin patches market size has grown steadily in recent years. It will grow from $7.36 billion in 2023 to $7.67 billion in 2024 at a compound annual growth rate (CAGR) of 4.2%. The growth observed in the historical period can be ascribed to factors such as a rising incidence of cardiovascular diseases, robust economic expansion in emerging markets, an uptick in pharmaceutical research and development (R&D) expenditure, and an overall increase in healthcare spending.

The transdermal skin patches market size is expected to see steady growth in the next few years. It will grow to $9.02 billion in 2028 at a compound annual growth rate (CAGR) of 4.1%. The growth in the forecast period can be attributed to factors such as the increasing focus on smoking cessation, the rapid growth in the aging population, rising healthcare expenditure, and the surge in cardiovascular diseases. Key trends in the forecast period include technological advancements in transdermal skin patches, progress in diabetes transdermal patches, robust research and development activities, product innovation, collaborations and partnerships, the emergence of wearable skin patches, advancements in microneedle patches for vaccination, and the introduction of new iontophoresis patches.

The escalating prevalence of cardiovascular diseases is expected to drive the growth of the transdermal skin patches market in the future. Cardiovascular diseases impact the heart and blood vessels, often associated with the development of fatty deposits in the arteries (atherosclerosis) and an increased risk of blood clots. Transdermal skin patches are utilized to prevent angina episodes (chest pain) in individuals with coronary artery disease (narrowing of blood vessels supplying blood to the heart) and to enhance bioavailability for the treatment of heart failure. For example, in May 2023, the Centers for Disease Control and Prevention reported that approximately 695,000 people in the United States died from heart disease in 2021, accounting for 1 in every 5 deaths. Coronary heart disease, the most prevalent type, caused 375,476 deaths in 2021. Consequently, the growing prevalence of cardiovascular diseases is steering the expansion of the transdermal skin patches market.

The growth of the transdermal skin patches market is significantly influenced by advancements in modern technologies. These technological advances are expanding the range of drugs that can be delivered transdermally, encompassing small molecule hydrophobic drugs, hydrophilic drugs, and macromolecules. The enhanced technological capabilities contribute to increased efficiency and the broader adoption of transdermal drug delivery systems (TDDS), consequently elevating the popularity and demand for TDDS. For instance, in September 2022, Corium, a biopharmaceutical company based in the United States, introduced Adlarity, a transdermal patch designed for Alzheimer's treatment. Utilizing the unique Corplex technology, Adlarity provides controlled and sustained release of donepezil, benefiting individuals with Alzheimer's-related dementia across various severity levels.

Leading companies in the transdermal skin patches market are intensifying their focus on introducing innovative products and securing approvals to establish a competitive advantage. Innovative products refer to novel or improved solutions addressing existing problems or needs, such as drugs or medical devices. In March 2022, Noven Pharmaceuticals Inc., a U.S.-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for XELSTRY (dextroamphetamine) transdermal system. This marked the first and only approved amphetamine patch for treating ADHD (Attention-Deficit or Hyperactivity Disorder). XELSTRYM, intended for use two hours before the required effect, provides sustained release for nine hours, allowing for personalized dosages based on clinical response and tolerability.

Major companies in the market are increasingly engaging in acquisitions and collaborations to enhance their presence and drive growth in the transdermal skin patches market. Strategic mergers, acquisitions, and collaborations enable companies to gain a technological edge and stay ahead in the competitive landscape. For instance, in December 2021, Boyd Corporation, a U.S.-based provider of advanced sealing and thermal management solutions, acquired MBK Tape Solutions. This acquisition enhances Boyd's expertise in medical material science, particularly in applications such as biosensors, transdermal patches, and advanced wound care. MBK Tape Solutions, a U.S.-based manufacturer of medical-grade adhesives, specializes in products designed for medical devices and transdermal patches.

In January 2022, Cumberland Pharmaceuticals Inc., a U.S.-based specialty pharmaceutical company, acquired Sancuso, a granisetron transdermal patch, from Kyowa Kirin for $13.5 million. This transaction granted Cumberland the U.S. rights to SANCUSO, enabling full control over its commercial aspects, including marketing, distribution, manufacturing, and medical support. SANCUSO, developed by Kyowa Kirin, is a transdermal patch delivering granisetron, a serotonin-3 (5-HT3) receptor antagonist, to prevent chemotherapy-induced nausea and vomiting (CINV).

Major companies operating in the transdermal skin patches market report are Novartis, Hisamitsu Pharmaceutical Co., Inc., Henan Lingrui Pharmaceutical, Teva Phamaceuticals, Luye Pharma Group Ltd., Purdue Pharma L.P., Nitto Denko Corporation, AdhexPharma, Noven Pharmaceuticals, Teikoku Pharma, Mylan Pharmaceuticals Inc., 3M Company, Acrux Ltd., Access Pharmaceuticals Inc., Rusan Pharma, Glenmark Pharmaceuticals, Cipla Ltd., Mundipharma, Dr Reddy's Laboratories, Chattem, Clarity Medical, Welcare Industries S.P. A, F.L. Medical S.r.l, Empire MEDICAL UK Ltd., Europlaz Technologies Ltd., Zentiva, Alfa-Med LLC, Medplant LLC, Medical-Lomza Sp. z o.o., P.H.U. Medical, ProVeterinare, Panop CZ, Allergan Inc., Johnson & Johnson, Boehringer Ingelheim GmbH, Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, Echo Therapeutics Inc., Endo Pharmaceuticals Inc.

North America was the largest region in the global transdermal skin patches market in 2023. Middle East is expected to be the fastest growing region in the transdermal skin patches market report during the forecast period. The regions covered in the transdermal skin patches market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the transdermal skin patches market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain

The transdermal skin patches market consists of sales of single-layer drug-in-adhesive, multi-layer drug-in-adhesive, and vapor patch. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Transdermal Skin Patches Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on transdermal skin patches market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for transdermal skin patches? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The transdermal skin patches market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Product: Matrix; Drug In Adhesive; Reservoir; Vapor
• 2) By Type: Fentanyl Transdermal Patch; Nicotine Transdermal Patch; Estradiol Transdermal Patch; Clonidine Transdermal Patch; Testosterone Transdermal Patch; Other Types
• 3) By Distribution Channel: Pain Relief; Nicotine Cessation; Hormone Replacement Therapy; Neurological Disorders; Cardiovascular Disorders; Other Applications
• Companies Mentioned: Novartis; Hisamitsu Pharmaceutical Co., Inc; Henan Lingrui Pharmaceutical; Teva Pharmaceuticals; Luye Pharma Group Ltd
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Transdermal Skin Patches Market Characteristics

3. Transdermal Skin Patches Market Trends And Strategies

4. Transdermal Skin Patches Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Transdermal Skin Patches Market Size and Growth

• 5.1. Global Transdermal Skin Patches Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Transdermal Skin Patches Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Transdermal Skin Patches Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Transdermal Skin Patches Market Segmentation

• 6.1. Global Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Matrix
• Drug In Adhesive
• Reservoir
• Vapor
• 6.2. Global Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Fentanyl Transdermal Patch
• Nicotine Transdermal Patch
• Buprenorphine Transdermal Patch
• Clonidine Transdermal Patch
• Oxybutynin Transdermal Patch
• Other Types
• 6.3. Global Transdermal Skin Patches Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Pain Relief
• Nicotine Cessation
• Hormone Replacement Therapy
• Neurological Disorders
• Cardiovascular Disorders
• Other Applications

7. Transdermal Skin Patches Market Regional And Country Analysis

• 7.1. Global Transdermal Skin Patches Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Transdermal Skin Patches Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Transdermal Skin Patches Market

• 8.1. Asia-Pacific Transdermal Skin Patches Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Transdermal Skin Patches Market

• 9.1. China Transdermal Skin Patches Market Overview
• 9.2. China Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Transdermal Skin Patches Market

• 10.1. India Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Transdermal Skin Patches Market

• 11.1. Japan Transdermal Skin Patches Market Overview
• 11.2. Japan Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Transdermal Skin Patches Market

• 12.1. Australia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Transdermal Skin Patches Market

• 13.1. Indonesia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Transdermal Skin Patches Market

• 14.1. South Korea Transdermal Skin Patches Market Overview
• 14.2. South Korea Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Transdermal Skin Patches Market

• 15.1. Western Europe Transdermal Skin Patches Market Overview
• 15.2. Western Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Transdermal Skin Patches Market

• 16.1. UK Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Transdermal Skin Patches Market

• 17.1. Germany Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Transdermal Skin Patches Market

• 18.1. France Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Transdermal Skin Patches Market

• 19.1. Italy Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Transdermal Skin Patches Market

• 20.1. Spain Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Transdermal Skin Patches Market

• 21.1. Eastern Europe Transdermal Skin Patches Market Overview
• 21.2. Eastern Europe Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Transdermal Skin Patches Market

• 22.1. Russia Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Transdermal Skin Patches Market

• 23.1. North America Transdermal Skin Patches Market Overview
• 23.2. North America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Transdermal Skin Patches Market

• 24.1. USA Transdermal Skin Patches Market Overview
• 24.2. USA Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Transdermal Skin Patches Market

• 25.1. Canada Transdermal Skin Patches Market Overview
• 25.2. Canada Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Transdermal Skin Patches Market

• 26.1. South America Transdermal Skin Patches Market Overview
• 26.2. South America Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Transdermal Skin Patches Market

• 27.1. Brazil Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Transdermal Skin Patches Market

• 28.1. Middle East Transdermal Skin Patches Market Overview
• 28.2. Middle East Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Transdermal Skin Patches Market

• 29.1. Africa Transdermal Skin Patches Market Overview
• 29.2. Africa Transdermal Skin Patches Market, Segmentation By Product, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Transdermal Skin Patches Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Transdermal Skin Patches Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Transdermal Skin Patches Market Competitive Landscape And Company Profiles

• 30.1. Transdermal Skin Patches Market Competitive Landscape
• 30.2. Transdermal Skin Patches Market Company Profiles
  • 30.2.1. Novartis
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Hisamitsu Pharmaceutical Co., Inc
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Henan Lingrui Pharmaceutical
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Teva Pharmaceuticals
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Luye Pharma Group Ltd
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Transdermal Skin Patches Market Other Major And Innovative Companies

• 31.1. Purdue Pharma L.P.
• 31.2. Nitto Denko Corporation
• 31.3. AdhexPharma
• 31.4. Noven Pharmaceuticals
• 31.5. Teikoku Pharma
• 31.6. Mylan Pharmaceuticals Inc
• 31.7. 3M Company
• 31.8. Acrux Ltd
• 31.9. Access Pharmaceuticals Inc
• 31.10. Rusan Pharma
• 31.11. Glenmark Pharmaceuticals
• 31.12. Cipla Ltd
• 31.13. Mundipharma
• 31.14. Dr Reddy's Laboratories
• 31.15. Chattem

32. Global Transdermal Skin Patches Market Competitive Benchmarking

33. Global Transdermal Skin Patches Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Transdermal Skin Patches Market

35. Transdermal Skin Patches Market Future Outlook and Potential Analysis

• 35.1 Transdermal Skin Patches Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Transdermal Skin Patches Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Transdermal Skin Patches Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer